Dr. Choueiri on the Research With Immunotherapy in RCC – OncLive
|
Dr. Choueiri on the Research With Immunotherapy in RCC
OncLive Toni Choueiri, MD, clinical director, Lank Center for Genitourinary Oncology, director, Kidney Cancer Center, senior physician, Dana-Farber Cancer Institute, discusses research involving immunotherapy regimens for patients with renal cell carcinoma (RCC). |
